Molecular mechanism of action of fluoride on bone cells

Journal of Bone and Mineral Research

Volumn 13, Issue 11, 1998, Pages 1660-1667

  Lau, K H William ^a,b   Baylink, David J ^a,b  

^a Jerry L Pettis VA Hospital   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; RAF PROTEIN; RAS PROTEIN;

ANIMAL CELL; BONE CELL; BONE DENSITY; BONE DEVELOPMENT; DRUG MECHANISM; HUMAN; HUMAN CELL; NONHUMAN; OSTEOPOROSIS; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SPINE FRACTURE;

ANIMALS; FLUORIDES; HUMANS; OSTEOBLASTS; OSTEOGENESIS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0031722817     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.11.1660     Document Type: Review

References (67)

1. Riggs BL, Hodgson SF, Hoffman DL, Kelly PJ, Johnson KA, Taves DR 1980 Treatment of primary osteoporosis with fluoride and calcium: Clinical tolerance and fracture occurrence. J Am Med Assoc 243:446-449.
2. Briancon D, Meunier PJ 1981 Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 12: 629-648.
3. Harrison JE, McNeill KG, Sturtridge WC, Bayley TA, Murray TM, Williams C, Tam C, Fornasier V 1981 Three-year changes in bone mineral mass of osteoporotic patients based on neutron activation analysis of the central third of the skeleton. J Clin Endocrinol Metab 52:751-758.
4. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ III 1990 Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802-809.
5. Riggs BL, O'Fallon WM, Lane A, Hodgson SF, Wahner HW, Muhs J, Chao E, Melton LJ III 1994 Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis. J Bone Miner Res 9:265-275.
6. Kleerekoper M, Peterson EL, Nelson DA, Phillips E, Schork MA, Tilley BC, Parfitt AM 1991 A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1:155-161.
7. Pak CYC, Sakhaee K, Piziak V, Peterson RD, Breslau NA, Boyd P, Poindexter JR, Herzog J, Heard-Sakhaee A, Haynes S, Adams-Huet B, Reisch JS 1994 Slow-release sodium fluoride in the management of postmenopausal osteoporosis: A randomized controlled trial. Ann Intern Med 120:625-632.
8. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR 1995 Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: Final report of a randomized controlled trial. Ann Intern Med 123:401-408.
9. Lau K-HW, Åkesson K, Libanati CR, Baylink DJ 1998 Osteogenic actions of fluoride: Its therapeutic use for established osteoporosis. In: Whitfield JF, Morley P (eds.) Anabolic Treatments for Osteoporosis. CRC Press Inc., Boca Raton, FL, U.S.A., pp. 207-254.
10. Farley JR, Wergedal JR, Baylink DJ 1983 Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science 222:330-332.
11. Baylink DJ 1993 Serum fluoride levels. In: Favus MJ (ed.) Primers on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2nd Ed. Raven Press, New York, NY, U.S.A., pp. 262-263.
12. Hall BK 1987 Sodium fluoride as an initiator of osteogenesis from embryonic mesenchyme in vitro. Bone 8:111-116.
13. Wergedal JE, Lau K-HW, Baylink DJ 1988 Fluoride and bovine bone extract influence cell proliferation and phosphatase activities in human bone cell cultures. Clin Orthop 233: 274-282.
14. 3H-thymidine incorporation and alkaline phosphatase production by human osteoblasts. Metabolism 39:1118-1121.
15. Lau K-HW, Yoo A, Wang SP 1991 Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride. Mol Cell Biochem 105:93-105.
16. Modrowski D, Miravet L, Feuga M, Bannie F, Marie PJ 1992 Effect of fluoride on bone and bone cells in ovariectomized rats. J Bone Miner Res 7:961-969.
17. Bellows CG, Aubin JE, Heersche JNM 1993 Differential effects of fluoride during initiation and progression of mineralization of osteoid nodules formed in vitro. J Bone Miner Res 8:1357-1363.
18. 3 potentiates fluoride-stimulated collagen type I production in cultures on human bone marrow stromal osteoblast-like cells. J Bone Miner Res 8:1453-1458.
19. 3H]thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor β. J Bone Miner Res 8:19-25.
20. Burgener D, Bonjour JP, Caverzasio J 1995 Fluoride increases tyrosine kinase activity in osteoblast-like cells: Regulatory role for the stimulation of cell proliferation and Pi transport across the plasma membrane. J Bone Miner Res 10:164-171.
21. Kassem M, Mosekilde L, Eriksen EF 1994 Effects of fluoride on human bone cells in vitro: Differences in responsiveness between stromal osteoblast precursors and mature osteoblasts. Acta Endocrinol 130:381-386.
22. 45Ca uptake by SaOS-2 cells: The effect is phosphate dependent. Calcif Tissue Int 53:187-192.
23. Zerwekh J, Morris A, Padalino P, Gottschalk F, Pak CYC 1990 Fluoride rapidly and transiently raises intracellular Ca in human osteoblasts. J Bone Miner Res 5 (Suppl 1):S131-S136.
24. Selz T, Caverzasio J, Bonjour J-P 1991 Fluoride selectively stimulates Na-dependent phosphate transport in osteoblast-like cells. Am J Physiol 260:E833-E838.
25. 3H]thymidine incorporation in embryonic chick calvarial cell cultures is dependent on the presence of a bone mitogen, sensitive to changes in the phosphate concentration, and modulated by systemic skeletal effectors. Metabolism 37:988-995.
26. Bellows CG, Heersche JNM, Aubin JE 1990 The effects of fluoride on osteoblast progenitors in vitro. J Bone Miner Res 5 (Suppl 1):S101-S105.
27. Farley JR, Tarbaux N, Hall S, Baylink DJ 1990 Mitogenic action(s) of fluoride on osteoblast line cells: Determinants of the response in vitro. J Bone Miner Res 5 (Suppl 1):S107-S113.
28. Kasperk CH, Wergedal JE, Strong DD, Farley JR, Wangerin K, Gropp H, Ziegler R, Baylink DJ 1995 Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab 80:2511-2517.
29. Lau K-HW, Farley JR, Freeman TK, Baylink DJ 1989 A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblastic acid phosphatase. Metabolism 38:858-868.
30. Thomas AB, Hashimoto H, Baylink DJ, Lau K-HW 1996 Fluoride at mitogenic concentrations increases the steady state phosphotyrosyl phosphorylation level of cellular proteins in human bone cells. J Clin Endocrinol Metab 81:2570-2578.
31. mapk, in human TE85 osteosarcoma cells. J Clin Endocrinol Metab 82:1126-1135.
32. Ullrich A, Schlessinger J 1990 Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
33. Fantl WJ, Johnson DE, Williams LT 1993 Signalling by receptors tyrosine kinases. Annu Rev Biochem 62:453-481.
34. Rozakis-Adcock M, McGlade J, Mbanaku G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG 1992 Association of she and Grbs/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692.
35. Haubruck H, McCormick F 1991 Ras p21: Effects and regulation. Biochim Biophys Acta 1072:215-229.
36. Morrison DK, Kaplan DR, Rapp U, Roberts TM 1988 Signal transduction from membrane to cytoplasm: Growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci USA 85:8855-8859.
37. Ellis C, Moran M, McCormick F, Pawson T 1990 Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343:377-381.
38. cdc42. Nature 363:364-367.
39. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL 1993 A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-319.
40. Pouyssegur J, Seuwen K 1992 Transmembrane receptors and intracellular pathways that control cell proliferation. Annu Rev Physiol 54:195-210.
41. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR 1991 Phosphorylation of c-jun mediated by MAP kinases. Nature 353:216-219.
42. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-416.
43. Lau K-HW, Farley JR, Baylink DJ 1985 Phosphotyrosyl specific protein phosphatase activity of a bovine skeletal acid phosphatase isoenzyme: Comparison with the phosphotyrosyl protein phosphatase activity of skeletal alkaline phosphatase. J Biol Chem 260:4653-4660.
44. Lau K-HW, Freeman TK, Baylink DJ 1987 Purification and characterization of a tartrate-resistant acid phosphatase that displays phosphotyrosyl protein phosphatase activity from bovine cortical bone matrix. J Biol Chem 262:1389-1397.
45. Lundy MW, Lau K-HW, Blair HC, Baylink DJ 1988 Chick osteoblasts contain fluoride-sensitive acid phosphatase activity. J Histochem Cytochem 36:1175-1180.
46. Wergedal JW, Lau K-HW 1992 Human bone cells contain a fluoride-sensitive acid phosphatase: Evidence that this enzyme functions at neutral pH as a phosphotyrosyl protein phosphatase. Clin Biochem 25:47-53.
47. Antonny B, Bigay J, Chabre M 1990 A novel magnesium-dependent mechanism for the activation of transduction by fluoride. FEBS Lett 268:277-280.
48. Lau K-HW, Tanimoto H, Baylink DJ 1988 Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro. Endocrinology 123:2858-2867.
49. Lau K-HW, Baylink DJ 1993 Phosphotyrosyl protein phosphatases: Potential regulators of cell proliferation and differentiation. Crit Rev Oncog 4:451-471.
50. Lau K-HW, Wu L-W, Baylink DJ 1995 Mitogenic action of fluoride on human bone cells is mediated through a sustained activation of the ras-Raf-MAPK signal transduction pathway by inhibition of phosphotyrosyl phosphatase activities. FASEB J 10:A1519 (abstract 2996).
51. Yoon HK, Baylink DJ, Lau K-HW 1995 Inhibition of tyrosyl phosphatases stimulates proliferation differentiation: Dependence of proliferation but not differentiation on tyrosyl kinase. J Bone Miner Res 10 (Suppl 1):S309 (abstract M228).
52. Caverzasio J, Imai T, Ammann P, Burgener D, Bonjour J-P 1996 Aluminum potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo. J Bone Miner Res 11:46-55.
53. Caverzasio J, Palmer G, Suzuki A, Bonjour J-P 1997 Mechanism of the mitogenic effect of fluoride on osteoblast-like cells: Evidence for a G protein-dependent tyrosine phosphorylation process. J Bone Miner Res 12:1975-1983.
54. Fields TA, Casey PJ 1997 Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321:561-571.
55. 2+ influx induced by BAY K8644 in FRTL-5 cells. Biochem Biophys Res Commun 190:801-807.
56. Dean NM, Kanemitsu M, Boynton AL 1989 Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem Biophys Res Commun 165:795-801.
57. Atluru S, Atluru D 1991 Evidence that genistein, a protein-tyrosine kinase inhibitor, inhibits CD28 monoclonal-antibody-stimulated human T cell proliferation. Transplanation 51:448-450.
58. Hashimoto H, Baylink DJ, Lau K-HW 1997 Evidence that the mitogenic action of fluoride (F) on human bone cells is mediated by F ion and not by the aluminum fluoride complex. J Bone Miner Res 12 (Suppl 1):S188 (abstract T347).
59. Florio T, Rim C, Hershberger RE, Loda M, Stork PJ 1994 The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 8: 1289-1297.
60. Yu Z, Ahmad S, Schwartz JL, Banville D, Shen SH 1997 Protein-tyrosine phosphatase SHP2 is positively linked to proteinase-activated receptor 2-mediated mitogenic pathway. J Biol Chem 272:7519-7524.
61. Imai A, Takagi H, Horibe S, Fuseya T, Tamaya T 1996 Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab 81:3249-3253.
62. Gaits F, Li RY, Bigay J, Ragab A, Ragab-Thomas MF, Chap H 1996 G-protein βγ subunits mediate specific phosphorylation of the protein-tyrosine phosphatase SH-PTP1 induced by lysophosphatidic acid. J Biol Chem 271:20151-20155.
63. Dent P, Reardon DB, Wood SL, Lindorfer MA, Graber SG, Garrison JC, Brautigan DL, Sturgill TW 1996 Inactivation of raf-1 by a protein-tyrosine phosphatase stimulated by GTP and reconstituted by Gαi/o subunits. J Biol Chem 271:3119-3123.
64. Todisco A, Seva C, Takeuchi Y, Dickinson CJ, Yamada T 1995 Somatostatin inhibits AP-1 function via multiple protein phosphatases. Am J Physiol 269:G160-G166.
65. Huang XC, Sumners C, Richards EM 1996 Angiotensin II stimulates protein phosphatase 2A activity in cultured neuronal cells via type 2 receptors in a pertussis toxin sensitive fashion. Adv Exp Med Biol 396:209-215.
66. Kawase T, Suzuki A 1989 Studies on the transmembrane migration of fluoride and its effects on proliferation of L-929 fibroblasts (L cells) in vitro. Arch Oral Biol 34:103-107.
67. Bourgoin SG, Harbour D, Poubelle PE 1996 Role of protein kinase Cα, Arf, and cytoplasmic calcium transient in phospholipase D activation by sodium fluoride in osteoblast-like cells. J Bone Miner Res 11:1655-1665.